{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:23:15Z","timestamp":1780510995050,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s41372-018-0275-8","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T09:12:57Z","timestamp":1544001177000},"page":"314-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Second trimester inflammatory and metabolic markers in women delivering preterm with and without preeclampsia"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1472-5630","authenticated-orcid":false,"given":"Kharah M.","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-1977","authenticated-orcid":false,"given":"Rebecca J.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Ryckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sky K.","family":"Feuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Bandoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Oltman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Dunkel Schetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Jelliffe-Pawlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,5]]},"reference":[{"key":"275_CR1","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nrneph.2014.102","volume":"10","author":"T Chaiworapongsa","year":"2014","unstructured":"Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10:466\u201380.","journal-title":"Nat Rev Nephrol"},{"key":"275_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(05)71003-5","volume":"365","author":"B Sibai","year":"2005","unstructured":"Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785\u201399.","journal-title":"Lancet"},{"key":"275_CR3","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1080\/14767058.2016.1185411","volume":"30","author":"RO Bahado-Singh","year":"2017","unstructured":"Bahado-Singh RO, Syngelaki A, Mandal R, Graham SF, Akolekar R, Han B, et al. Metabolomic determination of pathogenesis of late-onset preeclampsia. J Matern Fetal Neonatal Med. 2017;30:658\u201364.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"275_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.amjhyper.2004.03.666","volume":"17","author":"DA Enquobahrie","year":"2004","unstructured":"Enquobahrie DA, Williams MA, Butler CL, Frederick IO, Miller RS, Luthy DA. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens. 2004;17:574\u201381.","journal-title":"Am J Hypertens"},{"key":"275_CR5","doi-asserted-by":"crossref","unstructured":"Kelly RS, Croteau-Chonka DC, Dahlin A, Mirzakhani H, Wu AC, Wan ES, et al. Integration of metabolomic and transcriptomic networks in pregnant women reveals biological pathways and predictive signatures associated with preeclampsia. Metabolomics. 2017;13:1\u201315.","DOI":"10.1007\/s11306-016-1149-8"},{"key":"275_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bbrc.2017.02.032","volume":"485","author":"T Chen","year":"2017","unstructured":"Chen T, He P, Tan Y, Xu D. Biomarker identification and pathway analysis of preeclampsia based on serum metabolomics. Biochem Biophys Res Commun. 2017;485:119\u201325.","journal-title":"Biochem Biophys Res Commun"},{"key":"275_CR7","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/pd.2822","volume":"31","author":"AO Odibo","year":"2011","unstructured":"Odibo AO, Goetzinger KR, Odibo L, Cahill AG, Macones GA, Nelson DM, et al. First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study. Prenat Diagn. 2011;31:990\u20134.","journal-title":"Prenat Diagn"},{"key":"275_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/10641950801955725","volume":"27","author":"E Turner","year":"2008","unstructured":"Turner E, Brewster JA, Simpson NA, Walker JJ, Fisher J. Aromatic amino acid biomarkers of preeclampsia--a nuclear magnetic resonance investigation. Hypertens Pregnancy. 2008;27:225\u201335.","journal-title":"Hypertens Pregnancy"},{"key":"275_CR9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1161\/HYPERTENSIONAHA.110.157297","volume":"56","author":"LC Kenny","year":"2010","unstructured":"Kenny LC, Broadhurst DI, Dunn W, Brown M, North RA, McCowan L, et al. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension. 2010;56:741\u20139.","journal-title":"Hypertension"},{"key":"275_CR10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.59566\/IJBS.2012.8258","volume":"8","author":"S Schott","year":"2012","unstructured":"Schott S, Hahn J, Kurbacher C, Moka D. (31)P and (1)h nuclear magnetic resonance spectroscopy of blood plasma in female patients with preeclampsia. Int J Biomed Sci. 2012;8:258\u201363.","journal-title":"Int J Biomed Sci"},{"key":"275_CR11","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1021\/pr4002355","volume":"12","author":"SO Diaz","year":"2013","unstructured":"Diaz SO, Barros AS, Goodfellow BJ, Duarte IF, Galhano E, Pita C, et al. Second trimester maternal urine for the diagnosis of trisomy 21 and prediction of poor pregnancy outcomes. J Proteome Res. 2013;12:2946\u201357.","journal-title":"J Proteome Res"},{"key":"275_CR12","doi-asserted-by":"publisher","first-page":"857108","DOI":"10.1155\/2015\/857108","volume":"2015","author":"MP Koster","year":"2015","unstructured":"Koster MP, Vreeken RJ, Harms AC, Dane AD, Kuc S, Schielen PC, et al. First-trimester serum acylcarnitine levels to predict preeclampsia: a metabolomics approach. Dis Markers. 2015;2015:857108.","journal-title":"Dis Markers"},{"key":"275_CR13","doi-asserted-by":"publisher","first-page":"e98540","DOI":"10.1371\/journal.pone.0098540","volume":"9","author":"S Kuc","year":"2014","unstructured":"Kuc S, Koster MP, Pennings JL, Hankemeier T, Berger R, Harms AC, et al. Metabolomics profiling for identification of novel potential markers in early prediction of preeclampsia. PLoS ONE. 2014;9:e98540.","journal-title":"PLoS ONE"},{"key":"275_CR14","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/rcm.6941","volume":"28","author":"J Pinto","year":"2014","unstructured":"Pinto J, Maciel E, Melo TS, Domingues MR, Galhano E, Pita C, et al. Maternal plasma phospholipids are altered in trisomy 21 cases and prior to preeclampsia and preterm outcomes. Rapid Commun Mass Spectrom. 2014;28:1635\u20138.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"275_CR15","doi-asserted-by":"publisher","first-page":"21520","DOI":"10.3390\/ijms160921520","volume":"16","author":"M Austdal","year":"2015","unstructured":"Austdal M, Tangeras LH, Skrastad RB, Salvesen K, Austgulen R, Iversen AC, et al. First trimester urine and serum metabolomics for prediction of preeclampsia and gestational hypertension: a prospective screening study. Int J Mol Sci. 2015;16:21520\u201338.","journal-title":"Int J Mol Sci"},{"key":"275_CR16","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1097\/00004872-200411000-00021","volume":"22","author":"JE Ramsay","year":"2004","unstructured":"Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Divergent metabolic and vascular phenotypes in preeclampsia and intrauterine growth restriction: relevance of adiposity. J Hypertens. 2004;22:2177\u201383.","journal-title":"J Hypertens"},{"key":"275_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/01.ogx.0000256779.06275.c4","volume":"62","author":"N Visser","year":"2007","unstructured":"Visser N, van Rijn BB, Rijkers GT, Franx A, Bruinse HW. Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv. 2007;62:191\u2013201.","journal-title":"Obstet Gynecol Surv"},{"key":"275_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.preghy.2015.11.002","volume":"6","author":"BD Taylor","year":"2016","unstructured":"Taylor BD, Tang G, Ness RB, Olsen J, Hougaard DM, Skogstrand K, et al. Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls. Pregnancy Hypertens. 2016;6:72\u201378.","journal-title":"Pregnancy Hypertens"},{"key":"275_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/aji.12265","volume":"72","author":"KK Ferguson","year":"2014","unstructured":"Ferguson KK, McElrath TF, Chen YH, Mukherjee B, Meeker JD. Longitudinal profiling of inflammatory cytokines and C-reactive protein during uncomplicated and preterm pregnancy. Am J Reprod Immunol. 2014;72:326\u201336.","journal-title":"Am J Reprod Immunol"},{"key":"275_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/jre.12008","volume":"48","author":"A Chaparro","year":"2013","unstructured":"Chaparro A, Sanz A, Quintero A, Inostroza C, Ramirez V, Carrion F, et al. Increased inflammatory biomarkers in early pregnancy is associated with the development of pre-eclampsia in patients with periodontitis: a case control study. J Periodontal Res. 2013;48:302\u20137.","journal-title":"J Periodontal Res"},{"key":"275_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1600-0897.2012.01158.x","volume":"68","author":"R Boij","year":"2012","unstructured":"Boij R, Svensson J, Nilsson-Ekdahl K, Sandholm K, Lindahl TL, Palonek E, et al. Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia. Am J Reprod Immunol. 2012;68:258\u201370.","journal-title":"Am J Reprod Immunol"},{"key":"275_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1155\/2009\/658943","volume":"26","author":"M Swellam","year":"2009","unstructured":"Swellam M, Samy N, Wahab SA, Ibrahim MS. Emerging role of endothelial and inflammatory markers in preeclampsia. Dis Markers. 2009;26:127\u201333.","journal-title":"Dis Markers"},{"key":"275_CR23","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672\u201383.","journal-title":"N Engl J Med"},{"key":"275_CR24","doi-asserted-by":"crossref","unstructured":"Jelliffe-Pawlowski LL, Rand L, Bedell B, Baer RJ, Oltman SP, Norton ME, et al. Prediction of preterm birth with and without preeclampsia using mid-pregnancy immune and growth-related molecular factors and maternal characteristics. J Perinatol. 2018;38:963\u2012972.","DOI":"10.1038\/s41372-018-0112-0"},{"key":"275_CR25","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1126\/science.1251816","volume":"345","author":"R Romero","year":"2014","unstructured":"Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science. 2014;345:760\u20135.","journal-title":"Science"},{"key":"275_CR26","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1111\/1471-0528.13495","volume":"122","author":"LL Jelliffe-Pawlowski","year":"2015","unstructured":"Jelliffe-Pawlowski LL, Baer RJ, Blumenfeld YJ, Ryckman KK, O\u2019Brodovich HM, Gould JB, et al. Maternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of preterm birth. Bjog-Int J Obstet Gy. 2015;122:1484\u201393.","journal-title":"Bjog-Int J Obstet Gy"},{"key":"275_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175\u201391.","journal-title":"Behav Res Methods"},{"key":"275_CR28","unstructured":"Parrott JA, inventor. Determining existence of preeclampsia in pregnancies by measuring levels of glycerophosphatidyl compounds, glycerophosphatidycholine, lysophospholipids and lysophosphatidylcholine. 2002."},{"key":"275_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/aji.12239","volume":"72","author":"T Nagamatsu","year":"2014","unstructured":"Nagamatsu T, Iwasawa-Kawai Y, Ichikawa M, Kawana K, Yamashita T, Osuga Y, et al. Emerging roles for lysophospholipid mediators in pregnancy. Am J Reprod Immunol. 2014;72:182\u201391.","journal-title":"Am J Reprod Immunol"},{"key":"275_CR30","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/00001648-199911000-00013","volume":"10","author":"KE Innes","year":"1999","unstructured":"Innes KE, Byers TE. Preeclampsia and breast cancer risk. Epidemiology. 1999;10:722\u201332.","journal-title":"Epidemiology"},{"key":"275_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/0002-9378(93)90608-L","volume":"169","author":"J Mass\u00e9","year":"1993","unstructured":"Mass\u00e9 J, Forest J-C, Moutquin J-M, Marcoux S, Brideau N-A, B\u00e9langer M. A prospective study of several potential biologic markers for early prediction of the development of preeclampsia. Am J Obstet Gynecol. 1993;169:501\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"275_CR32","first-page":"222","volume":"71","author":"SW Walsh","year":"1988","unstructured":"Walsh SW. Progesterone and estradiol production by normal and preeclamptic placentas. Obstet Gynecol. 1988;71:222\u20136.","journal-title":"Obstet Gynecol"},{"key":"275_CR33","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/0002-9378(89)90931-9","volume":"161","author":"SW Walsh","year":"1989","unstructured":"Walsh SW, Coulter S. Increased placental progesterone may cause decreased placental prostacyclin production in preeclampsia. Am J Obstet Gynecol. 1989;161:1586\u201392.","journal-title":"Am J Obstet Gynecol"},{"key":"275_CR34","first-page":"362","volume":"112","author":"H Zeisler","year":"2000","unstructured":"Zeisler H, Sator MO, Joura EA. Serum levels of progesterone in patients with preeclampsia. Wien Klin Wochenschr. 2000;112:362\u20134.","journal-title":"Wien Klin Wochenschr"},{"key":"275_CR35","doi-asserted-by":"publisher","first-page":"862982","DOI":"10.1155\/2013\/862982","volume":"2013","author":"S Acikgoz","year":"2013","unstructured":"Acikgoz S, Bayar UO, Can M, Guven B, Mungan G, Dogan S, et al. Levels of oxidized LDL, estrogens, and progesterone in placenta tissues and serum paraoxonase activity in preeclampsia. Mediat Inflamm. 2013;2013:862982.","journal-title":"Mediat Inflamm"},{"issue":"D1","key":"275_CR36","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, et al. PubChem Substance and Compound databases: CID 70095. Nucleic Acids Res. 2016;44(D1):D1202\u20131213.","journal-title":"Nucleic Acids Res"},{"key":"275_CR37","first-page":"335","volume":"5","author":"B Bolar","year":"2018","unstructured":"Bolar B, Meshram GA. Isolation of octadecanedioic acid from Cassia Fistula Linn and its biological evaluation. Eur J Pharm Med Res. 2018;5:335\u20139.","journal-title":"Eur J Pharm Med Res"},{"key":"275_CR38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/aji.12563","volume":"76","author":"KM Ross","year":"2016","unstructured":"Ross KM, Miller G, Culhane J, Grobman W, Simhan HN, Wadhwa PD, et al. Patterns of peripheral cytokine expression during pregnancy in two cohorts and associations with inflammatory markers in cord blood. Am J Reprod Immunol. 2016;76:406\u201314.","journal-title":"Am J Reprod Immunol"},{"key":"275_CR39","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1021\/pr401068k","volume":"13","author":"H Luan","year":"2014","unstructured":"Luan H, Meng N, Liu P, Feng Q, Lin S, Fu J, et al. Pregnancy-induced metabolic phenotype variations in maternal plasma. J Proteome Res. 2014;13:1527\u201336.","journal-title":"J Proteome Res"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41372-018-0275-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-018-0275-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-018-0275-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T01:08:40Z","timestamp":1720832920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-018-0275-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,5]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["275"],"URL":"https:\/\/doi.org\/10.1038\/s41372-018-0275-8","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,5]]},"assertion":[{"value":"27 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}